# Immunotherapy-based therapy as a promising treatment for EGFR-mutant advanced non-small cell lung cancer patients after EGFR-TKI resistance

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/immunotherapy-based-therapy-as-a-promising-treatment-for-egfr-mutant-advanced/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jianghua Ding,Xinjing Ding,Zhaohui Leng |
| Citations | 11 |
| DOI | 10.1080/14737140.2023.2170879 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4317435185 |
| PMID | 36655635 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Jianghua Ding](https://scholariq.org/researchers/jianghua-ding/)
- [Zhaohui Leng](https://scholariq.org/researchers/zhaohui-leng/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.